Skip to main content
. 2023 Mar 31;12(3):406–424. doi: 10.21037/tau-23-21

Figure 1.

Figure 1

Mutation landscape and hub mutated genes in patients with advanced RCC from the CheckMate ICI therapy cohort. (A) Oncoplot for the mutated genes of 454 patients with advanced RCC from the CheckMate ICI therapy cohort. (B) PPI network of the mutated genes sorted by mutation frequencies in advanced RCC. The brighter color represented more interactions with adjacent genes. TMB, tumoral mutation burden; RCC, renal cell carcinoma; ICI, immune checkpoint inhibitor; PPI, protein–protein interaction.